BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 18833010)

  • 21. Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia.
    Yuste J; Botto M; Paton JC; Holden DW; Brown JS
    J Immunol; 2005 Aug; 175(3):1813-9. PubMed ID: 16034123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis.
    Worsøe L; Brandt CT; Lund SP; Ostergaard C; Thomsen J; Cayé-Thomasen P
    Otol Neurotol; 2010 Apr; 31(3):394-403. PubMed ID: 20147868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensorineural hearing loss in otitis media.
    Paparella MM; Morizono T; Le CT; Mancini F; Sipilä P; Choo YB; Lidén G; Kim CS
    Ann Otol Rhinol Laryngol; 1984; 93(6 Pt 1):623-9. PubMed ID: 6508134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery of the inner ear with hearing preservation: serial histological changes.
    Smouha EE
    Laryngoscope; 2003 Sep; 113(9):1439-49. PubMed ID: 12972912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the mouse model for acute otitis media.
    MacArthur CJ; Hefeneider SH; Kempton JB; Parrish SK; McCoy SL; Trune DR
    Hear Res; 2006 Sep; 219(1-2):12-23. PubMed ID: 16887307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model.
    Ogunniyi AD; LeMessurier KS; Graham RM; Watt JM; Briles DE; Stroeher UH; Paton JC
    Infect Immun; 2007 Apr; 75(4):1843-51. PubMed ID: 17261599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cochlear cytokine gene expression in murine acute otitis media.
    Ghaheri BA; Kempton JB; Pillers DA; Trune DR
    Laryngoscope; 2007 Jan; 117(1):22-9. PubMed ID: 17202925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical observation on sensorineural hearing loss secondary to secretory otitis media].
    Luo H; Feng T
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Aug; 36(4):295-7. PubMed ID: 12762001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Otitis media: the chinchilla model.
    Giebink GS
    Microb Drug Resist; 1999; 5(1):57-72. PubMed ID: 10332723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of pneumococcal inflammation: otitis media.
    Tuomanen EI
    Vaccine; 2000 Dec; 19 Suppl 1():S38-40. PubMed ID: 11163461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial tympanogenic labyrinthitis, meningitis, and sensorineural damage.
    Schachern PA; Paparella MM; Hybertson R; Sano S; Duvall AJ
    Arch Otolaryngol Head Neck Surg; 1992 Jan; 118(1):53-7. PubMed ID: 1728278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of CMV inflammatory genes in hearing loss.
    Schraff SA; Brown DK; Schleiss MR; Meinzen-Derr J; Greinwald JH; Choo DI
    Otol Neurotol; 2007 Oct; 28(7):964-9. PubMed ID: 17558342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Middle ear inflammatory mediators and cochlear function.
    Morizono T; Tono T
    Otolaryngol Clin North Am; 1991 Aug; 24(4):835-43. PubMed ID: 1870877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does chronic otitis media cause sensorineural hearing loss?
    Blakley BW; Kim S
    J Otolaryngol; 1998 Feb; 27(1):17-20. PubMed ID: 9511114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implication of pneumolysin as a virulence factor in Streptococcus pneumoniae endophthalmitis.
    Ng EW; Samiy N; Rubins JB; Cousins FV; Ruoff KL; Baker AS; D'Amico DJ
    Retina; 1997; 17(6):521-9. PubMed ID: 9428015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitigation of hearing loss from semi-circular canal transection in pseudomonas otitis media with ciprofloxacin-dexamethasone irrigation.
    Shefelbine SE; Young LJ; Antonelli PJ
    Otol Neurotol; 2006 Feb; 27(2):265-9. PubMed ID: 16436999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term hearing loss in gerbils with bacterial meningitis treated with superoxide dismutase.
    Ge NN; Brodie HA; Tinling SP
    Otol Neurotol; 2008 Dec; 29(8):1061-7. PubMed ID: 18849884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac.
    Rappaport JM; Bhatt SM; Burkard RF; Merchant SN; Nadol JB
    J Infect Dis; 1999 Jan; 179(1):264-8. PubMed ID: 9841852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of pneumococcal phase variation, host and pressure/gas composition: virulence expression of NanA, HylA, PspA and CbpA in simulated otitis media.
    Li-Korotky HS; Lo CY; Banks JM
    Microb Pathog; 2010 Oct; 49(4):204-10. PubMed ID: 20576489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of hearing loss in an animal model of pneumococcal meningitis.
    Kesser BW; Hashisaki GT; Spindel JH; Ruth RA; Scheld WM
    Otolaryngol Head Neck Surg; 1999 May; 120(5):628-37. PubMed ID: 10229585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.